老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Reviva Pharmaceuticals Holdings, Inc.

0.7208
-0.0248-3.33%
成交量：36.07万
成交额：26.53万
市值：3,369.02万
市盈率：-0.80
高：0.7709
开：0.7440
低：0.7027
收：0.7456
数据加载中...
总览公司新闻公告
2021/09/20

重要事件披露

8-K - Current report
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/16

重要事件披露

8-K - Current report
2021/06/16

重要事件披露

8-K - Current report
2021/06/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/03

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/25

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/25

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/25

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/19

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/17

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/05/10

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/07

重要事件披露

8-K - Current report
2021/05/07

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/19

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/04/15

重要事件披露

8-K - Current report
2021/03/24

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/22

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
更多